Inspire Medical Systems Inc (INSP)
249.72
-1.47
(-0.59%)
USD |
NYSE |
May 03, 16:00
249.83
+0.11
(+0.04%)
After-Hours: 20:00
Inspire Medical Systems Research and Development Expense (Quarterly): 31.05M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 31.05M |
September 30, 2023 | 29.14M |
June 30, 2023 | 30.82M |
March 31, 2023 | 25.52M |
December 31, 2022 | 21.25M |
September 30, 2022 | 20.99M |
June 30, 2022 | 14.53M |
March 31, 2022 | 11.87M |
December 31, 2021 | 10.29M |
September 30, 2021 | 9.614M |
June 30, 2021 | 9.288M |
March 31, 2021 | 8.154M |
December 31, 2020 | 7.285M |
September 30, 2020 | 7.307M |
Date | Value |
---|---|
June 30, 2020 | 6.062M |
March 31, 2020 | 5.438M |
December 31, 2019 | 3.767M |
September 30, 2019 | 3.623M |
June 30, 2019 | 2.846M |
March 31, 2019 | 2.603M |
December 31, 2018 | 2.152M |
September 30, 2018 | 1.771M |
June 30, 2018 | 1.735M |
March 31, 2018 | 1.73M |
December 31, 2017 | 1.682M |
September 30, 2017 | 1.176M |
June 30, 2017 | 1.743M |
March 31, 2017 | 1.593M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.846M
Minimum
Jun 2019
31.05M
Maximum
Dec 2023
13.62M
Average
9.614M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
Conmed Corp | 13.59M |
Cutera Inc | 4.564M |
Stereotaxis Inc | 2.212M |
Electromed Inc | 0.107M |
Myomo Inc | 0.878M |